AutoGenomics Withdraws IPO for Second Time | GenomeWeb

NEW YORK (GenomeWeb News) – AutoGenomics once again withdrew its planned initial public offering after failing to meet a Feb. 15 deadline to provide its latest financial information to the US Securities and Exchange Commission, a company official confirmed to GenomeWeb Daily News.

Ramanath Vairavan, senior vice president of sales and marketing for the Vista, Calif.-based molecular diagnostics firm, said that the company hopes to refile for an IPO in the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genetic method to gauge age of ancient samples, genetic polymorphisms in mouse strain, and more.

Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.

Lita Nelsen from the Massachusetts Institute of Technology's technology-transfer office is retiring after decades there.

After nine years, the Canadian government is loosening its restrictions on government scientists' ability to speak to the press and public.